A modified vaccinia virus Ankara (MVA-survivin) expressing survivin was constructed by Ishizaki et al., who also explored its effect on pancreatic cancer models in combination with gemcitabine 110. The gene discussed is BIRC5; the disease is pancreatic neoplasm.